Speakers at the Coalition for Healthcare Communication conference discussed how regulations from the White House and FDA have affected healthcare comms.
Plan D: Experts predict government savings, but higher co-pays with Trump plan for lowering drug pricesMay 21, 2018
The White House's strategy calls for moving expensive treatments from under Medicare Part B to Medicare Part D.
For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.
Pharma stocks were up after the President went easy on drugmakers.
FDA approval of Gilead HIV drug prompts ViiV patent suit; Poll shows split in voter reaction to Trump opioid plan; Outcome Health partners with CDC.
CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices 'a priority'
Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.